INS and metabolic syndrome: Figure 6 summarizes our findings: metabolomic analysis identified a CAF biomarker signature consistent with rapid-onset Metabolic Syndrome and elevated mitochondrial dysregulation that corresponds to weight gain, HOMA-IR measures of insulin sensitivity, hyperglycemia, pro-inflammatory macrophage infiltration of adipose and crown-like structure formation.